ArticleRespiratory research2026
H3K18 lactylation promotes allergic airway inflammation in asthma via a CSF1/CSF1R/MAPK autocrine axis.
Article in Respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Glycolytic reprogramming and cell-specific lactylation in asthma: an evidence-graded framework for testable metabolic-epigenetic profiles.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundMetabolic reprogramming of airway epithelial cells is a hallmark of asthma, yet the mechanisms by which altered metabolism drives inflammation remain largely unknown. Histone lactylation, a recently identified metabolism-derived epigenetic modification, may provide a mechanistic link.
methodsClinical specimens and single-cell RNA sequencing (scRNA-seq) were analyzed to map the metabolic landscape of asthma. Histone lactylation in airway epithelial cells was assessed by western blotting and immunofluorescence. Functional roles of histone lactylation were evaluated via modulation of glycolysis, lactate availability, or P300 expression. Chromatin immunoprecipitation sequencing (ChIP-seq) and RNA sequencing (RNA-seq) were performed to identify transcriptional targets of H3K18 lactylation (H3K18la).
resultsGlycolysis and histone lactylation, particularly H3K18la, were significantly elevated in the airway epithelial cells of asthma. Inhibition of glycolysis or P300 knockdown attenuated the inflammatory response by suppressing histone lactylation; whereas lactate supplementation exacerbated inflammation by promoting histone lactylation. H3K18la accumulated at the CSF1R promoter, directly enhancing its transcription and establishing a CSF1/CSF1R/MAPK autocrine positive feedback axis that positions airway epithelial cells as an upstream driver and inflammatory amplifier in allergic airway inflammation.
conclusionThis study defines a glycolysis-histone lactylation-CSF1R signaling axis that links epithelial metabolic reprogramming to sustained inflammatory gene activation in asthma, highlighting histone lactylation as a potential therapeutic target for allergic airway inflammation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.